Charles River Laboratories stock hits 52-week low at $160.73

Published 29/01/2025, 15:40
Charles River Laboratories stock hits 52-week low at $160.73

Charles River Laboratories International Inc. (CRL) stock has reached a new 52-week low, touching down at $160.73. This latest price point marks a significant downturn for the company, which has seen a -27.13% decline over the past year. InvestingPro analysis indicates the stock is currently in oversold territory, with four analysts recently revising their earnings expectations downward. Investors are closely monitoring the stock as it navigates through a challenging period, with market analysts scrutinizing the factors that could have contributed to this decline. Despite the current downturn, InvestingPro data shows the company maintains a "GOOD" overall financial health score, and analysis suggests the stock is currently undervalued. The 52-week low serves as a critical indicator for potential shifts in the company’s stock performance and investor sentiment. As Charles River Laboratories continues to adapt to the evolving market conditions, stakeholders are keenly awaiting the company’s strategic responses to this financial trough. Discover more valuable insights and 12+ additional ProTips with an InvestingPro subscription.

In other recent news, Charles River Laboratories is facing a series of challenges. S&P Global revised the company’s credit outlook to stable from positive due to weak 2025 guidance, with expected revenue decline and operating margin pressure. Analysts from William Blair, UBS, and TD Cowen have downgraded the company’s stock rating or cut the price target due to various concerns including revenue pressures, anticipated mid-term sales growth pressures, and uncertainty surrounding biotech funding for 2025.

Furthermore, the potential suspension of worldwide trade in wild monkeys from Cambodia, a key resource for Charles River, has raised concerns for the company’s revenue. Evercore ISI has noted that non-human primates are expected to contribute approximately $650 million to the company’s revenue by 2025. These are recent developments and investors should note that analysts maintain a consensus price target above current levels, suggesting potential upside despite near-term headwinds.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.